Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Research

Language Development

Language is one of the most remarkable developmental accomplishments of early childhood. Language connects us with others and is an essential tool for literacy, education, employment and lifelong learning.

Researchers make progress on 'superhero' phage therapy

Cystic fibrosis (CF) researchers are working hard to progress phage therapy as an alternative treatment to antibiotics in people with CF who develop life-threatening lung infections.

Precision health accelerator takes some of the guesswork out of research

Running any research project is a feat of logistical gymnastics – and often, you don’t know what can go wrong until it happens.

Pneumococcal vaccine sees hospital admissions for deadly pneumonia slashed

New research has revealed the extraordinary impact of a collaborative project between The Kids Research Institute Australia and the Papua New Guinea Institute of Medical Research, with rates of hospitalisation for pneumonia dropping by nearly 60 per cent thanks to the introduction of the pneumococcal vaccine

The decades old program helping families and kids to thrive

It’s a brave move to upend your entire family to seek a fresh start – or safety – in a new country: even braver when the country you’re moving to has a completely different language, structure and cultural outlook.

Phage therapy a CF ‘game changer’

Cutting-edge work is offering new hope to children with Cystic Fibrosis.

The day time stood still for little Manna

Patricia Ilchuk can still recall the day in August 2020 when her daughter Manna – then five weeks old – had her first seizure.

Childhood Depression

It's normal for children and teenagers to experience a range of emotions, including sadness, however childhood depression is more than just feeling sad.

Research

Melanoma

Melanoma, also known as malignant melanoma, occurs when abnormal skin cells multiply rapidly in an uncontrolled way.

Research

Rethinking a hybrid malaria chemoprevention delivery strategy for children in sub-perennial settings: a modelling study integrating age- and seasonally-targeted delivery

The World Health Organization recommends perennial malaria chemoprevention (PMC), generally using sulfadoxine-pyrimethamine (SP) to children at high risk of severe Plasmodium falciparum malaria. Currently, PMC is given up to age two in perennial transmission settings. However, no recommendation exists for perennial settings with seasonal variation in transmission intensity, recently categorized as 'sub-perennial'.